x None
Entity Type
0001758736
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 Molecular Data Inc.
Jurisdiction of Incorporation/Organization
CAYMAN ISLANDS
 
Year of Incorporation/Organization
  o Over Five Years Ago
  x Within Last Five Years (Specify Year) 2018
  o Yet to Be Formed  



2. Principal Place of Business and Contact Information
Name of Issuer  
 Molecular Data Inc.  
Street Address 1 Street Address 2
 5/F, Bldg. 12, 1001 North Qinzhou Rd,  Xuhui District
City State/Province/Country ZIP/Postal Code Phone No. of Issuer
 Shanghai  CHINA  201109  +86 21 5436-5166 



3. Related Persons
Last Name First Name Middle Name
Wang Zheng
Street Address 1 Street Address 2
5/F, Bldg. 12, 1001 North Qinzhou Rd, Xuhui District
City State/Province/Country ZIP/Postal Code
Shanghai CHINA 201109
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last Name First Name Middle Name
Chang Dongliang
Street Address 1 Street Address 2
5/F, Bldg. 12, 1001 North Qinzhou Rd, Xuhui District
City State/Province/Country ZIP/Postal Code
Shanghai CHINA 201109
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last Name First Name Middle Name
Ma Dawei
Street Address 1 Street Address 2
Shanghai Institute of Organic Chemistry 345 Lingling Lu
City State/Province/Country ZIP/Postal Code
Shanghai CHINA 200032
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last Name First Name Middle Name
Zhu Ning
Street Address 1 Street Address 2
Room 606, 211 West Huaihai Road
City State/Province/Country ZIP/Postal Code
Shanghai CHINA 200030
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

 
Last Name First Name Middle Name
Wang Yanbin
Street Address 1 Street Address 2
416 W Grant Pl. Unit E
City State/Province/Country ZIP/Postal Code
Chicago ILLINOIS 60614
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last Name First Name Middle Name
Li Zhaohong
Street Address 1 Street Address 2
5/F, Bldg. 12, 1001 North Qinzhou Rd, Xuhui District
City State/Province/Country ZIP/Postal Code
Shanghai CHINA 201109
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 

Last Name First Name Middle Name
Sun Qiaoqiao
Street Address 1 Street Address 2
5/F, Bldg. 12, 1001 North Qinzhou Rd, Xuhui District
City State/Province/Country ZIP/Postal Code
Shanghai CHINA 201109
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 

 


4. Industry Group
o Agriculture   Health Care o Retailing
  Banking & Financial Services   o Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance   Technology
  o Insurance   o Hospitals & Physicians   o Computers
  o Investing   o Pharmaceuticals   o Telecommunications
  o Investment Banking   o Other Health Care   o Other Technology
  o Pooled Investment Fund

        Travel
  o Other Banking & Financial Services o Manufacturing   o Airlines & Airports
  Real Estate   o Lodging & Conventions
  o Commercial   o Tourism & Travel Services
  o Construction   o Other Travel
  o REITS & Finance o Other
  o Residential  
  o Other Real Estate  
x Business Services  
  Energy  
  o Coal Mining  
  o Electric Utilities  
  o Energy Conservation  
  o Environmental Services  
  o Oil & Gas  
  o Other Energy  


5. Issuer Size
Revenue Range Aggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
x Over $100,000,000 o Over $100,000,000
o Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale  2020-10-09 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests x Equity
o Tenant-in-Common Securities x Debt
o Mineral Property Securities o Option, Warrant or Other Right to Acquire Another Security
x Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
   


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary)  
  

11. Minimum Investment
Minimum investment accepted from any outside investor $ 0 USD

12. Sales Compensation
Recipient Recipient CRD Number o None
   
(Associated) Broker or Dealer o None (Associated) Broker or Dealer CRD Number o None
   
Street Address 1 Street Address 2
   
City State/Province/Country ZIP/Postal Code
     
State(s) of Solicitation o All States
 
 



13. Offering and Sales Amounts
Total Offering Amount $ 5000000 USD o Indefinite
Total Amount Sold $ 3000000 USD  
Total Remaining to be Sold $ 2000000 USD o Indefinite
 
Clarification of Response (if Necessary)
  


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 1


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions $ 0 USD o Estimate
Finders' Fees $ 0 USD o Estimate
 
Clarification of Response (if Necessary)
  


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
  $ 0 USD o
Molecular Data (NASDAQ:MKD)
Historical Stock Chart
From Nov 2021 to Dec 2021 Click Here for more Molecular Data Charts.
Molecular Data (NASDAQ:MKD)
Historical Stock Chart
From Dec 2020 to Dec 2021 Click Here for more Molecular Data Charts.